SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Trends in development and approval times for new therapeutics in the United States · Study

ArticleShelves

ArticleTrends in development and approval times for new therapeutics in the United States

Janice M. Reichert2003

Article2003

Trends in development and approval times for new therapeutics in the United States

Janice M. Reichert

260 citations·0/0 files stored·Nature Reviews Drug Discovery

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Pharmaceutical Economics and Policy Pharmaceutical industry and healthcare Biomedical Ethics and Regulation

Abstract

No abstract was published for this record.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 260 citations exist upstream.

Cited by

2011An Empirical Review of Major Legislation Affecting Drug Development: Past Experiences, Effects, and Unintended Consequences 2006Are Development Times For Pharmaceuticals Increasing Or Decreasing?2004Science, pharmacoeconomics and ethics in drug R&D: a sustainable future scenario?2018How do patent-based measures inform product commercialization? —The case of the United States pharmaceutical industry

Details

Year2003

Typearticle

Published2003-09-01

VenueNature Reviews Drug Discovery

ISSN-L1474-1776

Languageen

Citations260

Files0 public / 0

ShelfPharmaceutical Economics and Policy

Identifiers

doi10.1038/nrd1178

openalex_workW1502809559

Links

Imported from OpenAlex (CC0) — nothing here is generated.